Trial Profile
Efficacy and safety of the combination therapy with Ipragliflozin for the cases who have insufficient effect by oral hypoglycemic agents
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 22 Jun 2020
Price :
$35
*
At a glance
- Drugs Ipragliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 18 Feb 2015 New trial record